172 related articles for article (PubMed ID: 38353903)
1. Anti-CD38 targeted nanotrojan horses stimulated by acoustic waves as therapeutic nanotools selectively against Burkitt's lymphoma cells.
Vighetto V; Conte M; Rosso G; Carofiglio M; Sidoti Abate F; Racca L; Mesiano G; Cauda V
Discov Nano; 2024 Feb; 19(1):28. PubMed ID: 38353903
[TBL] [Abstract][Full Text] [Related]
2. Iron-Doped ZnO Nanoparticles as Multifunctional Nanoplatforms for Theranostics.
Carofiglio M; Laurenti M; Vighetto V; Racca L; Barui S; Garino N; Gerbaldo R; Laviano F; Cauda V
Nanomaterials (Basel); 2021 Oct; 11(10):. PubMed ID: 34685064
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices.
Dumontel B; Susa F; Limongi T; Vighetto V; Debellis D; Canta M; Cauda V
Cell Biosci; 2022 May; 12(1):61. PubMed ID: 35568919
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of low intensity ultrasound effects on living cells: from simulation to experiments.
Tamboia G; Campanini M; Vighetto V; Racca L; Spigarelli L; Canavese G; Cauda V
Biomed Microdevices; 2022 Oct; 24(4):35. PubMed ID: 36279001
[TBL] [Abstract][Full Text] [Related]
5. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and DNAzyme using ZnO@polydopamine core-shell nanocomposites for chemo/gene/photothermal therapy.
Liu M; Peng Y; Nie Y; Liu P; Hu S; Ding J; Zhou W
Acta Biomater; 2020 Jul; 110():242-253. PubMed ID: 32438113
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
8. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
9. Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine.
Wang J; Lee JS; Kim D; Zhu L
ACS Appl Mater Interfaces; 2017 Nov; 9(46):39971-39984. PubMed ID: 29076344
[TBL] [Abstract][Full Text] [Related]
10. Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.
Kanavi MR; Asadi S; Balagholi S; Alikarami F; Nosrati H; Ahmadieh H
J Appl Clin Med Phys; 2018 May; 19(3):268-275. PubMed ID: 29707895
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
12. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
13. A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
Lapalombella R; Zhao X; Triantafillou G; Yu B; Jin Y; Lozanski G; Cheney C; Heerema N; Jarjoura D; Lehman A; Lee LJ; Marcucci G; Lee RJ; Caligiuri MA; Muthusamy N; Byrd JC
Clin Cancer Res; 2008 Jan; 14(2):569-78. PubMed ID: 18223233
[TBL] [Abstract][Full Text] [Related]
14. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.
Lin W; Fan S; Liao K; Huang Y; Cong Y; Zhang J; Jin H; Zhao Y; Ruan Y; Lu H; Yang F; Wu C; Zhao D; Fu Z; Zheng B; Xu JF; Pi J
Front Cell Infect Microbiol; 2022; 12():1074533. PubMed ID: 36776549
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Phenomena between Iron-Doped ZnO Nanoparticles and Shock Waves Exploited against Pancreatic Cancer Cells.
Carofiglio M; Conte M; Racca L; Cauda V
ACS Appl Nano Mater; 2022 Nov; 5(11):17212-17225. PubMed ID: 36851991
[TBL] [Abstract][Full Text] [Related]
16. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
18. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
19. Zinc Oxide Nanocrystals and High-Energy Shock Waves: A New Synergy for the Treatment of Cancer Cells.
Racca L; Limongi T; Vighetto V; Dumontel B; Ancona A; Canta M; Canavese G; Garino N; Cauda V
Front Bioeng Biotechnol; 2020; 8():577. PubMed ID: 32582682
[TBL] [Abstract][Full Text] [Related]
20. Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
Ferry JA
Oncologist; 2006 Apr; 11(4):375-83. PubMed ID: 16614233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
